GOSSELIES, Belgium--(BUSINESS WIRE)--Delphi Genetics SA has announced today a new license agreement for the use of the StabyExpress® technology in the food industry. The technology will be used for the production of enzymes for food processing.
Under the agreement, the company receives a non-exclusive worldwide license to use the StabyExpress™ technology for enzyme production in GMP conditions. In exchange, Delphi is eligible to receive upfront and milestone payments associated with the development of the product that utilize the StabyExpress® technology, as well as royalties on sales of such product.
Help employers find you! Check out all the jobs and post your resume.
